Use of a bispecific antibody in the preparation of a medicament for treating cancer

A bispecific antibody is developed to address the lack of effective therapies for advanced solid tumors, offering enhanced treatment efficacy.

HK40135199APending Publication Date: 2026-07-17SHANGHAI HANSOH BIOMEDICAL CO LTD +2
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
SHANGHAI HANSOH BIOMEDICAL CO LTD
Filing Date
2026-06-08
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing treatments for advanced solid tumors lack effective therapeutic options, particularly in the context of bispecific antibody-based therapies.

Method used

Development of a bispecific antibody for targeted cancer therapy, specifically designed to treat advanced solid tumors.

Benefits of technology

The bispecific antibody provides a targeted therapeutic approach enhancing treatment efficacy for advanced solid tumors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Provided is the use of a bispecific antibody in the manufacture of a medicament for the treatment of cancer, in particular in the manufacture of a medicament for the treatment of advanced solid tumors.
Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480062890.0 (22) Application Date 2024.09.27 (66) Domestic Priority Data 202311283448.4 2023.09.28 CN (85) PCT International Application Entering National Phase Date 2026.03.30 (86) PCT International Application Application Data PCT / CN2024 / 121938 2024.09.27 (87) PCT International Application Publication Data WO2025 / 067492 ZH 2025.04.03 (71) Applicant Shanghai Hansoh Biomedical Technology Co., Ltd. Address 201203 Pudong New Area, Shanghai, China (Shanghai) No. 3728, Jinke Road, Free Trade Zone, Building 11 Applicant: Changzhou Hengbang Pharmaceutical Co., Ltd. Bai'ou Entai (Zhuhai) Pharmaceutical R&D Co., Ltd. (72) Inventors: Ma Xiaoying, Qian Hui, Zhou Yuanfeng, Chen Lili (74) Patent Agency: Shanghai Bisheng Intellectual Property Agency Co., Ltd. 31347 Patent Attorney: Yuan Hong (51) Int.Cl. A61K 39 / 395 (2006.01) C07K 16 / 28 (2006.01) C07K 16 / 46 (2006.01) A61P 35 / 00 (2006.01) (54) Invention Title: Use of a Bispecific Antibody in the Preparation of a Drug for Treating Cancer (57) Abstract: This invention provides the use of a bispecific antibody in the preparation of a drug for treating cancer, particularly in the preparation of a drug for treating advanced solid tumors. CN 122028932 A 2026.05.12 CN 1 22 02 89 32 A